Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of central nervous system (CNS) agents. Its structure supports the design of bioactive molecules due to the presence of the trifluoromethyl group, which enhances metabolic stability and membrane permeability. Commonly employed in medicinal chemistry for optimizing lead compounds in drug discovery programs targeting neurological disorders and psychiatric conditions. Also utilized in the preparation of selective enzyme inhibitors and receptor modulators where lipophilicity and electronic effects are critical for activity.